Xeris Biopharma Holdings Inc (XERS): Next-Year EPS Estimate 153.44%
As of 2026-06-11, Xeris Biopharma Holdings Inc (XERS) has a next-year EPS growth estimate of 153.44%.
On 2026-05-14, analyst consensus for XERS's next-year EPS growth shifted from 161.29% to 153.44% — a negative change of 7.85 percentage points. The revised estimate has been sustained across 21 subsequent trading sessions. Current-year growth is projected at 4425.82%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 153.44%
- EPS growth this year
- 4425.82%
- EPS next quarter (est)
- $0.01
- Last price
- $6.93
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 153.44% | 4425.82% | $0.01 | $6.93 |
| 2026-06-10 | 153.44% | 4425.82% | $0.01 | $6.71 |
| 2026-06-09 | 153.44% | 4425.82% | $0.01 | $6.50 |
| 2026-06-08 | 153.44% | 4425.82% | $0.01 | $6.24 |
| 2026-06-07 | 153.44% | 4425.82% | $0.01 | $6.18 |
| 2026-06-04 | 153.44% | 4425.82% | $0.01 | $6.15 |
| 2026-06-03 | 153.44% | 4425.82% | $0.01 | $5.89 |
| 2026-06-02 | 153.44% | 4425.82% | $0.01 | $6.00 |
| 2026-06-01 | 153.44% | 4425.82% | $0.01 | $6.07 |
| 2026-05-31 | 153.44% | 4425.82% | $0.01 | $6.16 |
| 2026-05-28 | 153.44% | 4425.82% | $0.01 | $6.32 |
| 2026-05-27 | 153.44% | 4425.82% | $0.01 | $6.23 |
| 2026-05-26 | 153.44% | 4425.82% | $0.01 | $6.26 |
| 2026-05-25 | 153.44% | 4425.82% | $0.01 | $6.19 |
| 2026-05-24 | 153.44% | 4425.82% | $0.01 | $6.19 |
| 2026-05-21 | 153.44% | 4425.82% | $0.01 | $6.38 |
| 2026-05-20 | 153.44% | 4425.82% | $0.01 | $6.23 |
| 2026-05-19 | 153.44% | 4425.82% | $0.01 | $5.92 |
| 2026-05-18 | 153.44% | 4425.82% | $0.01 | $6.01 |
| 2026-05-17 | 153.44% | 4425.82% | $0.01 | $6.24 |
| 2026-05-14 | 153.44% | 4425.82% | $0.01 | $6.38 |
| 2026-05-13 | 161.29% | 4042.72% | $0.01 | $6.44 |
| 2026-05-12 | 161.29% | 4042.72% | $0.01 | $6.26 |
| 2026-05-11 | 161.29% | 4042.72% | $0.01 | $6.14 |
| 2026-05-10 | 161.29% | 4042.72% | $0.01 | $6.53 |
| 2026-05-07 | 168.06% | 3864.55% | $0.02 | $6.63 |
| 2026-05-06 | 181.63% | 3641.81% | $0.00 | $6.37 |
| 2026-05-05 | 181.63% | 3641.81% | $0.00 | $6.23 |
| 2026-05-04 | 181.63% | 3641.81% | $0.00 | $6.34 |
| 2026-05-03 | 181.63% | 3641.81% | $0.00 | $6.28 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Xeris Biopharma Holdings Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Xeris Biopharma Holdings Inc (XERS) has a next-year EPS growth estimate of 153.44%, based on analyst consensus.
When was the latest EPS estimate revision for XERS?▾
The most recent revision occurred on 2026-05-14, when analysts adjusted the next-year EPS growth estimate from 161.29% to 153.44%.
What sector and industry does Xeris Biopharma Holdings Inc belong to?▾
Xeris Biopharma Holdings Inc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. XERS appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Xeris Biopharma Holdings Inc (XERS) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports